5-HT receptor subtypes involved in the serotonin-induced inhibition of L-leucine absorption in rabbit jejunum

Life Sciences

Volumn 61, Issue 3, 1997, Pages 309-318

  Salvador, M T ^a   Rodriguez Yoldi M C ^a   Alcalde, A I ^a   Rodriguez Yoldi M J ^a  

^a UNIVERSIDAD DE ZARAGOZA   (Spain)

Author keywords

5 HT agonists; 5 HT antagonists; Intestinal absorption; Jejunum; L leucine; Rabbit

Indexed keywords

1 METHYL 3 INDOLECARBOXYLIC ACID [1 [2 (METHYLSULFONYLAMINO)ETHYL] 4 PIPERIDINYLMETHYL] ESTER; 2 METHYLSEROTONIN; 5 CARBAMOYLTRYPTAMINE; ALPHA METHYLSEROTONIN; LEUCINE; METITEPINE; ONDANSETRON; RADIOISOTOPE; RECEPTOR SUBTYPE; RITANSERIN; SEROTONIN; SEROTONIN 1 RECEPTOR; SEROTONIN 2 RECEPTOR; SEROTONIN 3 RECEPTOR; SEROTONIN 4 RECEPTOR; SEROTONIN AGONIST; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR; ZACOPRIDE;

AMINO ACID TRANSPORT; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; INTESTINE ABSORPTION; JEJUNUM; MALE; NONHUMAN; RABBIT;

ANIMALS; BENZAMIDES; BICYCLO COMPOUNDS, HETEROCYCLIC; INDOLES; INTESTINAL ABSORPTION; JEJUNUM; LEUCINE; MALE; ONDANSETRON; RABBITS; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT3; RECEPTORS, SEROTONIN, 5-HT4; RITANSERIN; SEROTONIN; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; SULFONAMIDES;

EID: 0343196670     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(97)00387-1     Document Type: Article

References (46)

1. RUBIN W., SCHWARTZ B. Gastroenterology. 76:1979;437-449.
2. M.D. GERSHON, G.M. MAWE and T.A. BRANCHEK, Peripheral actions of 5-hydroxytryptamine , J.R. Fozard (Ed), 247-273, New York; Oxford Univ. Press, (1989).
3. V.S. ELBROND, V. DANTZER, T.M. MAYHEW and E. SKADHAUGE, Avian endocrinology , P.J. Sharp (Ed), 217-226, Bristol: Journal of endocrinology Ltd., (1993).
4. KELLUM J.M., BUDHOO M.R., SIRIWARDENA A.K., SMITH E.P., JEBRAILI S.A. Am. J. Physiol. 267:1994;G357-G363.
5. BJORCK S., AHLMAN H., DAHLSTROM A., PHILLIPS S.F., KELLY K.A. Acta Physiol. Scand. 133:1988;247-256.
6. H.J. COOKE, Current topics in gastroenterology. New York, Elsivier Science Publishing Co. 23-48 (1991).
7. COSTALL B., NAYLOR R.J. Scand. J. Gastroenterol. 25:1990;769-787.
8. GERSHON M.D., WADE P.R., KIRCHGESSNER A.L., TAMIR H. Neuropsychopharmacology. 3:1990;385-395.
9. SANGER G.J. Can. J. Physiol. Pharmacol. 68:1990;314-324.
10. BOCKAERT J., FOZARD J.R., DUMUIS A., CLARKE D.E. Trends Pharmacol. Sci. 13:1992;141-145.
11. AHLMAN H., DAHLSTROM A., GRONSTAD K.O., TISELL K.E., OBERG K., ZINNER M.J., JAFFE B.M. Ann. Surg. 201:1985;81.
12. COUPE M., ANDERSON J., BARNARD M., ALSTEAD E., BLOOM S.R., HODGSON H.J.F. Gut. 27:1986;A1243.
13. ANDERSON J.V., COUPE M.O., MORRIS J.A., HODGSON H.J.F., BLOOM S.R. Br. Med. J. 294:1987;1129.
14. EHERER A., PETRITSCH V., HOLZER-PETSCHE H., HINTERLEITNER T.H., BEUBLER E., KREJS G.J. Gastroenterology. 100:1991;A685.
15. GUSTAFSEN J., LENDORF A., BOESBY S. Scand. J. Gastroenterol. 21:1986;816.
16. WOOLLARD D.J., BORNSTEIN J.C., FURNESS J.B. Naunyn-Schmiedebergs Arch. Pharmacol. 349:1994;455-462.
17. GAGINELLA T.S., RIMELE T.J., WIETECHA M. J. Physiol. Lond. 335:1983;101-111.
18. SIRIWARDENA A.J., BOOKER C., PRATT J., KELLUM J.M. Surgery St. Louis. 110:1991;411-418.
19. M.D. GERSHON, P.R. WADE, E. FIORICA-HOWELSE, A.L. KIRCHGESSNER and H. TAMIR, Serotonin: Molecular biology, Receptors and Functional Effects . J.R. Saxena (Ed), 133-142, Basel: Birkhauser Verlag (1991).
20. NORTH R.A. Sem. Neurosci. 1:1989;81.
21. SALVADOR M.T., RODRIGUEZ-YOLDI M.C., ALCALDE A.I., MARCO R., RODRIGUEZ-YOLDI M.J. Life Sci. 59(15):1996;1269-1281.
22. R.G.D. STEEL and J.H. TORRIE, Principles and procedures of statistics. A biometrial approach . McGraw-Hill book Company, Inc New York (1980).
23. BUNCE K.T., ELSWOOD C.J., BALL M.T. Br. J. Pharmacol. 102:1991;811-816.
24. DUMUIS A., BOUHELAL R., SEBBEN M., CORY R., BOCKAERT J. Mol. Pharmacol. 34:1988;880-887.
25. DUMUIS A., SEBBEN M., BOSKAERT J. Naunyn-Schmiedebergs Arch. Pharmacol. 340:1989;403-410.
26. HANSEN M.B., THORBOLL J.E., SKADHAUGE E. J. Comp. Physiol. B. 164:1994;343-348.
27. HANSEN M.B., THORBOLL J.E., BEUBLER E., SKADHAUGE E. Physiol. Res. 43:1994;83-93.
28. HANSEN M.B. Pharmacology and Toxicology. 76:1995;136-140.
29. HANSEN M.B., JAFFE B.M. J. Surg. Res. 56:1994;277-287.
30. HANSEN M.B. Pharmacology and Toxicology. 77:1995;3-39.
31. HOYER D., CLARKE D.E., FOZARD J.R., HARTIG P.R., MARTIN G.R., MYLECHARANE E.J., SAXENA P.R., HUMPHREY P.P.A. Pharmacol. Rev. 46:1994;157-203.
32. COOKE H.J., CAREY H.V. Eur. J. Pharmacol. 111:1985;329-337.
33. EBERLE-WANG K., BRAUN B.T., SIMANSKY K.J. Am. J. Physiol. 266:1994;R284-R291.
34. MORIARTY K.J., HIGGS N.B., WOODFORD M., WARHURST G., TURNBERG L.A. Gut. 28:1987;844-848.
35. SCHUITZ B.D., HOMAIDAN F., DONOWITZ M., SHARP G.W.G. FASEB J. 2:1988;A1722.
36. A.K. SIRIWARDENA, E.H. SMITH, E.H. BORUM and J.M. KELLUM, Am. J. Physiol. 265 G339-46 (1993).
37. DERKACH V., SURPRENANT A., NORTH R.A. Nature. 339:1989;706-709.
38. J.R. FOZARD, Cardiovascular Pharmacology of 5-Hydroxytryptamine . P.R. Saxena, D.I. Wallis, W. Wouters and P. Bevan (Eds), 101-115, Kluwer, Dordrecht (1990).
39. ANSANAY H., SEBBEN M., BOCKAERT J., DUMUIS A. Mol. Pharmacol. 42:1992;808-816.
40. RHODES K.F., COLEMAN J., LATTIMER N. Naunyn-Schmiedebergs Arch. Pharmacol. 346:1992;496-503.
41. P.P.A. HUMPHREY, P.R. HARTIG and D.A. HOYER, Proceeding of the 2nd international Symposium on Serotonin: from cell biology to pharmacology and therapeutics. Kluwer Press (1993).
42. HANSEN M.B. Comp. Biochem. Physiol. 101:1992;283-288.
43. J. HARDCASTLE and P.T. HARDCASTLE, J. Physiol. Lond. Proceeding of the Physiological Society, Sheffield meeting, 79P (1991).
44. BURLEIGH D.E., BORMAN P.A. Eur. J. Pharmacol. 241:1993;125-128.
45. GEBAUER A., MERGER M, KILBINGER H. Naunyn-Schmiedebergs Arch. Pharmacol. 347:1993;137-140.
46. GROSSMAN C.J., KILPATRICK G.J., BUNCE K.T. Br. J. Pharmacol. 109:1993;618-624.